Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response by Gentile et al to Letters Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".

Circulation·2026
Same author

A mathematical model of cell adhesion on soft surfaces.

Journal of the mechanical behavior of biomedical materials·2026
Same author

Deep docking, part 2: an amplified DDU platform for ultra-large virtual screening.

Chemical science·2026
Same author

ChatGPT in the diagnosis and management of complex polyneuropathies: comparative analysis with neurologists using real-world cases.

NPJ digital medicine·2026
Same author

Obstructive Sleep Apneas and Cardiovascular Diseases.

Clocks & sleep·2026
Same author

Clinical Translatable and Transparency of Neural Network for Blood-Based Personalized Cancer Risk.

Mayo Clinic proceedings. Digital health·2026

Related Experiment Video

Updated: Dec 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

941

Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery.

Francesco Gentile1, Vibudh Agrawal1, Michael Hsing1

  • 1Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia V6H3Z6, Canada.

ACS Central Science
|July 2, 2020
PubMed
Summary

Deep Docking (DD) accelerates drug discovery by rapidly screening billions of molecules using deep learning. This novel platform significantly reduces data and enriches high-scoring compounds for faster identification of potential drug candidates.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

766

Related Experiment Videos

Last Updated: Dec 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

941
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

766

Area of Science:

  • Computational chemistry
  • cheminformatics
  • Artificial intelligence in drug discovery

Background:

  • Drug discovery is a lengthy and expensive process, often taking decades and billions of dollars.
  • Virtual screening methods like molecular docking accelerate drug discovery but struggle with massive chemical databases exceeding billions of records.
  • The rapid expansion of chemical libraries presents opportunities but necessitates faster screening protocols.

Purpose of the Study:

  • To introduce Deep Docking (DD), a novel deep learning platform for rapid and accurate docking of billions of molecular structures.
  • To address the challenge of screening vast chemical libraries in drug discovery.
  • To provide a computationally efficient method for identifying potential drug candidates.

Main Methods:

  • Developed Deep Docking (DD), a deep learning platform utilizing quantitative structure-activity relationship (QSAR) deep models.
  • Trained QSAR models on docking scores from subsets of chemical libraries to predict outcomes for unprocessed entries.
  • Iteratively removed unfavorable molecules to approximate docking outcomes.
  • Integrated DD with the FRED docking program for screening.

Main Results:

  • Successfully screened 1.36 billion molecules from the ZINC15 library against 12 target proteins.
  • Achieved up to 100-fold data reduction and 6000-fold enrichment of high-scoring molecules.
  • Demonstrated rapid and accurate calculation of docking scores without significant loss of favorable entities.
  • Validated the DD methodology's effectiveness in large-scale virtual screening.

Conclusions:

  • Deep Docking (DD) offers a significant advancement in accelerating drug discovery by enabling rapid screening of massive chemical libraries.
  • The DD platform provides an efficient and accurate method for identifying promising drug candidates from billions of molecules.
  • The DD protocol is versatile, compatible with any docking program, and has been made publicly available for broader research use.